Menveo® Meningitis Vaccine Indicated for People 10 Years Through 55 Years of Age Meningococcal (Groups A, C, Y AND W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine 10 mcg - 5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL 2021233496

Menveo® Meningitis Vaccine Indicated for People 10 Years Through 55 Years of Age Meningococcal (Groups A, C, Y AND W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine 10 mcg - 5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL

Trumenba® Meningitis Vaccine Indicated for People 10 Through 25 Years of Age Meningococcal Group B Vaccine 120 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL 202944570

Trumenba® Meningitis Vaccine Indicated for People 10 Through 25 Years of Age Meningococcal Group B Vaccine 120 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL

MenQuadfi Meningitis Vaccine Indicated for People 2 Years of Age and Older Meningococcal (Groups A, C, Y, and W-135) Conjugate Vaccine, Preservative Free 10 mcg

$1,143.84
MENQUADFI VACCINE, SDV 10MCG/0.5ML (5/CT)
SKU
1001191780
Discontinued, See Alternate

Product Specifications

SLI Medical #1191780
Manufacturer #49281059005
BrandMenQuadfi™
ManufacturerSanofi Pasteur
Country of OriginFrance
ApplicationMeningitis Vaccine
Container TypeSingle-Dose Vial
Dosage FormInjection
Generic Drug Code47972
Generic Drug NameMeningococcal (Groups A
NDC Number C
Product Dating Y
Storage Requirements and W-135) Conjugate Vaccine
Strength Preservative Free
Type49281059005
UNSPSC CodeSLI Medical Acceptable Dating: we will ship >= 180 days
UserRequires Refrigeration
Volume10 mcg / 0.5 mL
Intramuscular
51201610
Indicated for People 2 Years of Age and Older
0.5 mL

Features

  • MenQuadfi is a vaccine indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A
  • C
  • W
  • and Y
MENQUADFI VACCINE, SDV 10MCG/0.5ML (5/CT)